Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions. (Q40540239)
scientific article published on November 2003
Language:
(P31) (Q13442814)
(P50) (Q68283994)
(P304) 1235-1244
(P407) (Q1860)
(P433) 11
(P478) 37
(P577) Saturday, November 1, 2003
(P921) (Q12252367)
(P1433) (Q5500025)
(P1476) "Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions" (language: en)
(P2093) Peter J Kirkpatrick
Peter L Weissberg
Iain R Challis
Ian F Dennis
Mark A Freeman
Malcolm J Mitchinson
(P2860) (Q34423117)
(Q29617216)
(Q46534157)
(Q41169190)
(Q33828621)
(Q29391553)
(Q41186840)
(Q35379559)
(Q34743416)
(Q44303454)
(Q43952380)
(Q34368058)
(Q54166560)
(Q42068195)
(Q41019483)
(Q28364452)
(Q44302068)
(Q44324611)
(Q74514968)
(Q71060539)
(Q73365511)
(Q70644879)
(Q68366198)
(Q77794005)
(Q70932480)
(Q68140228)
(Q77407922)
other details
description scientific article published on November 2003

External Links